| Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 A Silvin, N Chapuis, G Dunsmore, AG Goubet, A Dubuisson, L Derosa, ... Cell 182 (6), 1401-1418. e18, 2020 | 764 | 2020 |
| Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage A Fluckiger, R Daillere, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ... Science 369 (6506), 936-942, 2020 | 265 | 2020 |
| Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients L Derosa, B Routy, M Fidelle, V Iebba, L Alla, E Pasolli, N Segata, ... European urology 78 (2), 195-206, 2020 | 244 | 2020 |
| Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade G Ferrere, MT Alou, P Liu, AG Goubet, M Fidelle, O Kepp, S Durand, ... JCI insight 6 (2), 2021 | 185 | 2021 |
| A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets M Salou, F Legoux, J Gilet, A Darbois, A du Halgouet, R Alonso, W Richer, ... Journal of Experimental Medicine 216 (1), 133-151, 2019 | 177 | 2019 |
| Immune responses during COVID-19 infection C Melenotte, A Silvin, AG Goubet, I Lahmar, A Dubuisson, A Zumla, ... Oncoimmunology 9 (1), 1807836, 2020 | 158 | 2020 |
| Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers FX Danlos, C Grajeda-Iglesias, S Durand, A Sauvat, M Roumier, D Cantin, ... Cell death & disease 12 (3), 1-11, 2021 | 138 | 2021 |
| The impact of the intestinal microbiota in therapeutic responses against cancer AG Goubet, R Daillère, B Routy, L Derosa, PM Roberti, L Zitvogel Comptes rendus biologies 341 (5), 284-289, 2018 | 75 | 2018 |
| Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis S Yonekura, S Terrisse, C Alves Costa Silva, A Lafarge, V Iebba, ... Cancer discovery 12 (4), 1128-1151, 2022 | 53 | 2022 |
| Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis AG Goubet, A Dubuisson, A Geraud, FX Danlos, S Terrisse, CAC Silva, ... Cell Death & Differentiation 28 (12), 3297-3315, 2021 | 41 | 2021 |
| Escherichia coli–Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer AG Goubet, L Lordello, C Alves Costa Silva, I Peguillet, M Gazzano, ... Cancer Discovery 12 (10), 2280-2307, 2022 | 35 | 2022 |
| Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer S Terrisse, AG Goubet, K Ueda, AM Thomas, V Quiniou, C Thelemaque, ... Journal for immunotherapy of cancer 10 (3), 2022 | 34 | 2022 |
| Multifaceted modes of action of the anticancer probiotic Enterococcus hirae AG Goubet, R Wheeler, A Fluckiger, B Qu, F Lemaître, K Iribarren, ... Cell Death & Differentiation 28 (7), 2276-2295, 2021 | 23 | 2021 |
| BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer M Rouanne, J Adam, C Radulescu, D Letourneur, D Bredel, S Mouraud, ... The Journal of clinical investigation 132 (12), 2022 | 20 | 2022 |
| Antibiotics prescription to decrease progression-free survival (PFS) and overall survival (OS) in patients with advanced cancers treated with PD1/PDL1 immune checkpoint inhibitors. L Derosa, B Routy, L Mezquita, C Naltet, D Enot, M Fidelle, AG Goubet, ... Journal of Clinical Oncology 35 (15_suppl), 3015-3015, 2017 | 15 | 2017 |
| The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy IndividualsT-cell … JE Fahrner, I Lahmar, AG Goubet, Y Haddad, A Carrier, M Mazzenga, ... Cancer Discovery, OF1-OF26, 2022 | 14 | 2022 |
| Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients M Bourgin, L Derosa, CAC Silva, AG Goubet, A Dubuisson, FX Danlos, ... Aging (Albany NY) 13 (17), 20860, 2021 | 13 | 2021 |
| Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors R Daillère, B Routy, AG Goubet, A Cogdill, G Ferrere, C Alves-Costa Silva, ... Oncoimmunology 9 (1), 1794423, 2020 | 13 | 2020 |
| Immunodynamics of explanted human tumors for immuno‐oncology A Dubuisson, JE Fahrner, AG Goubet, S Terrisse, N Voisin, C Bayard, ... EMBO molecular medicine 13 (1), e12850, 2021 | 10 | 2021 |
| Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1+ Antiangiogenesis in Malignant Pleural Mesothelioma FX Danlos, M Texier, B Job, S Mouraud, L Cassard, C Baldini, A Varga, ... Cancer Discovery 13 (4), 858-879, 2023 | 9 | 2023 |
